Company Comparison
Karuna Therapeutics vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Karuna Therapeutics | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Boston, MA | South San Francisco, California |
| Founded | 2009 | 2006 |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
Karuna Therapeutics
A clinical-stage biopharmaceutical company focused on developing novel therapies for psychiatric and neurological conditions.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
Karuna Therapeutics
Sector Overlap
Both Karuna Therapeutics and 23andMe operate in Biotech.
Browse all Biotech companies →